If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
290.00    0.00 (0.00%)
Bid:
280.00
Ask:
300.00
Spread: 20.00 (7.143%)
Market Cap: £50.46m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

Trading Update

11 Apr 2025 07:00

RNS Number : 6015E
Character Group PLC (The)
11 April 2025
 

 

 

Friday, 11 April 2025

 

 

The Character Group plc

("Character", the "Company" or the "Group")

Trading update

 

The recent unilateral imposition by the USA of trade tariffs on imports, particularly from China, and the escalating retaliatory measures being adopted have greatly impacted global economic stability in a very short space of time. 

 

The Board's visibility for forecasting sales to USA (which were c.20% of Group turnover in the last financial year) and its ability to assess the financial implications for the Group have been considerably obscured by these events. Consequently, the effect of the imposition of the trade tariffs will be felt in the second half by the Group and, as a result, the Company is withdrawing the market guidance for the year ending 31 August 2025. Despite this, the Board remains confident that the Group will be profitable for the current financial year as a whole.

 

The review of the Company's H1 results, which are due to be published in mid-May, is not yet complete, however, all indications at this time are that, in accordance with market expectations, the trading results to February 2025 will be in line with the first-half performance in the prior year (HY 2024 profit before tax and highlighted items: £2.1m).

 

The Company continues to have a strong balance sheet with healthy cash balances and the Board is confident that it can ride out this storm. As we gain a clearer picture of the global economic landscape emerging, we will update shareholders further.

 

 

 

 

 

Enquiries to:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Hamun Shah, Group Finance Director

Office: +44 (0) 208 329 3377

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited (Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal / Tony Quirke, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFEFSEISESL
Date   Source Headline
2nd Jun 20155:12 pmRNSHolding(s) in Company
30th Apr 20157:00 amRNSHalf Yearly Report - ended 28 February 2015
12th Mar 20153:00 pmRNSBlocklisting Interim Review
27th Feb 20155:29 pmRNSTotal Voting Rights
20th Feb 20158:19 amRNSTransaction in Own Shares
13th Feb 201510:07 amRNSHolding(s) in Company
12th Feb 20151:02 pmRNSDirectors share dealing/Transaction in own shares
9th Feb 20151:34 pmRNSDirector's share dealing/Transaction in own shares
6th Feb 20158:26 amRNSTransaction in Own Shares
30th Jan 20153:09 pmRNSTotal Voting Rights
29th Jan 20154:02 pmRNSTransaction in Own Shares
26th Jan 20158:00 amRNSTransaction in Own Shares
21st Jan 20158:00 amRNSCharacter-Toy Supplier and Product awards
16th Jan 201511:55 amRNSResult of AGM
16th Jan 20157:00 amRNSTrading Update
2nd Jan 20159:12 amRNSHolding(s) in Company
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20144:38 pmRNS2014 Annual Financial Report
3rd Dec 20147:00 amRNSStatement re Preliminary results year to 31.8.14
26th Nov 20144:05 pmRNSNotice of Preliminary results
6th Nov 20147:00 amRNSCharacter features strongly in DreamToys listing
31st Oct 201410:01 amRNSTotal Voting Rights
30th Oct 201410:19 amRNSReplacement Total Voting Rights
2nd Oct 20144:48 pmRNSTransaction in Own Shares
30th Sep 201411:36 amRNSTransaction in Own Shares
29th Sep 20149:30 amRNSDirector/PDMR Shareholding
26th Sep 20147:00 amRNSDirector/PDMR Shareholding
9th Sep 201412:53 pmRNSHolding(s) in Company
8th Sep 201410:00 amRNSMaster worldwide licence for Teletubbies secured
8th Sep 20147:00 amRNSTrading Update
31st Jul 20142:22 pmRNSTotal Voting Rights
18th Jul 20149:05 amRNSDirector/PDMR Shareholding
30th Jun 20142:27 pmRNSTotal Voting Rights
9th Jun 20144:14 pmRNSTransaction in Own Shares
9th Jun 201412:47 pmRNSBlocklisting Interim Review
5th Jun 20144:43 pmRNSTransaction in Own Shares
2nd Jun 20142:54 pmRNSTotal Voting Rights
30th May 20142:56 pmRNSTransaction in Own Shares
27th May 20143:37 pmRNSTransaction in Own Shares
22nd May 20143:01 pmRNSTransaction in Own Shares
20th May 201412:08 pmRNSTransaction in Own Shares
16th May 201412:15 pmRNSTransaction in Own Shares
12th May 20146:28 pmRNSDirector/PDMR Shareholding
1st May 20147:00 amRNSHY - six months to 28 February 2014
11th Apr 20141:28 pmRNSHolding(s) in Company
5th Mar 20143:02 pmRNSTotal Voting Rights
4th Feb 20143:50 pmRNSTotal Voting Rights
22nd Jan 20145:12 pmRNSNon Regulatory Announcement
17th Jan 20142:45 pmRNSStatement re AGM
17th Jan 20147:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.